Document is current
Any future updates will be listed below
-
Authors
Emens, Leisha A https://orcid.org/0000-0002-7694-0731
Adams, Sylvia
Cimino-Mathews, Ashley https://orcid.org/0000-0002-0638-7969
Disis, Mary L
Gatti-Mays, Margaret E https://orcid.org/0000-0001-8914-2897
Ho, Alice Y
Kalinsky, Kevin
McArthur, Heather L
Mittendorf, Elizabeth A
Nanda, Rita
Page, David B https://orcid.org/0000-0001-9264-4628
Rugo, Hope S https://orcid.org/0000-0001-6710-4814
Rubin, Krista M
Soliman, Hatem
Spears, Patricia A
Tolaney, Sara M https://orcid.org/0000-0002-5940-8671
Litton, Jennifer K
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04443348 at ClinicalTrials.govnct03546686 at ClinicalTrials.govDocuments that mention this clinical trial
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer
https://doi.org/10.1136/jitc-2021-002597
First-in-human study of SBRT and adenosine pathway blockade to potentiate the benefit of immunochemotherapy in early-stage luminal B breast cancer: results of the safety run-in phase of the Neo-CheckRay trial
https://doi.org/10.1136/jitc-2023-007279
nct03362060 at ClinicalTrials.govDocuments that mention this clinical trial
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer
https://doi.org/10.1136/jitc-2021-002597
A single-arm phase 2 study of peri-operative immune checkpoint inhibition and cryoablation in women with hormone receptor-negative, HER2-negative, early-stage/resectable breast cancer.
https://doi.org/10.1200/jco.2023.41.16_suppl.tps635
nct04443348 at ClinicalTrials.govDocuments that mention this clinical trial
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer
https://doi.org/10.1136/jitc-2021-002597
nct02779751 at ClinicalTrials.govDocuments that mention this clinical trial
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer
https://doi.org/10.1136/jitc-2021-002597
First-in-human study of SBRT and adenosine pathway blockade to potentiate the benefit of immunochemotherapy in early-stage luminal B breast cancer: results of the safety run-in phase of the Neo-CheckRay trial
https://doi.org/10.1136/jitc-2023-007279
Documents that mention this clinical trial
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer
https://doi.org/10.1136/jitc-2021-002597
CDK4/6 inhibitors in the treatment of patients with breast cancer: summary of a multidisciplinary round-table discussion
https://doi.org/10.1136/esmoopen-2018-000368
Dendritic cell therapy augments antitumor immunity triggered by CDK4/6 inhibition and immune checkpoint blockade by unleashing systemic CD4 T-cell responses
https://doi.org/10.1136/jitc-2022-006019
- License Information
